BioSante Pharma (BPAX) Posts Wider than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts BPAX Hot Sheet
Price: $1.09 --0%
Financial Fact:
DILUTED NET LOSS PER SHARE (in dollars per share): 0.22
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
DILUTED NET LOSS PER SHARE (in dollars per share): 0.22
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
BioSante Pharmaceuticals, Inc. (Nasdaq: BPAX) reported Q1 loss of $0.20, $0.06 worse than the analyst estimate of ($0.14).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
